🎁 Black Friday: up to 50% off of annual plans
Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
7.74
-0.19 (-2.40%)
At close: Nov 20, 2026, 4:00 PM EST
8.16
+0.42 (5.43%)
After-hours: Nov 20, 2026, 7:56 PM EST

Moleculin Biotech Stock Forecast

MBRX's stock price has decreased by -96.47% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 3 analysts polled by S&P Global, Moleculin Biotech stock has a consensus rating of "Strong Buy" and an average price target of $240. The average 1-year stock price forecast is 3,000.78% higher than the current stock price, while the lowest is $40 (+416.80%) and the highest is $620 (+7,910.34%).

Price Target: $240 (+3,000.78%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$40$240$60$620
Change+416.80%+3000.8%+675.19%+7910.3%

Analyst Ratings

The average analyst rating for Moleculin Biotech stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Sep '26Nov '26
Strong Buy222222
Buy111111
Hold000000
Sell000000
Strong Sell000000
Total333333

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Maxim Group
Maxim Group
Buy
Maintains
$40
BuyMaintains$40+416.80%Nov 17, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Maintains
$60
BuyMaintains$60+675.19%Sep 29, 2026
Roth MKM
Roth MKM
Buy
Maintains
$620
BuyMaintains$620+7,910.34%Aug 5, 2026

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.43K
from -955.52
EPS Next Year
-2.21K
from -2.43K
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
------
Operating Income
-22.97M-30.64M-29.63M-26.64M-25.10M-28.76M
Net Income
-15.89M-29.03M-29.77M-26.05M-33.56M-33.75M
EPS
-----955.52-2,425.00
Free Cash Flow
------39.90M
No. Analysts
-----3
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
Highn/a
Avgn/a
Lown/a

Revenue Growth

Revenue Growth20272028
High-
Avg-
Low-

EPS Forecast

EPS202620272028
High-2,425.00
Avg-2,425.00
Low-2,425.00

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-